Numerous studies have demonstrated that probiotics can alleviate skin inflammation and enhance skin barrier function in AD patients by promoting the activity of regulatory T cells (Tregs) and suppressing the production of pro-inflammatory cytokines, including IL-6 and TNF-α (Mahmud et al., 2022; Emokpae et al., 2024). The gene discussed is IL6; the disease is dermatitis.